We believe definition

We believe. RPI has developed novel technology that may offer a potential breakthrough for the treatment of Hepatitis C," said Xxxx X. Xxxxxxx, Ph.D.,vice president of infectious diseases discovery research and clinical investigation for Lilly. "Our collaboration with RPI gives us an opportunity to further expand our efforts in this important medical area." "We look forward to collaborating with Lilly in the development of novel therapeutics to treat HCV. The recent results with HEPTAZYME are very encouraging and take us one step closer to providing an effective treatment for the HCV," said Xx. Xxxxx Xxxxxxxxxxxxxx, Ph.D., Chief Executive Officer and President of RPI. Lilly is a global research-based pharmaceutical corporation headquartered in Indianapolis, Indiana, that is dedicated to creating and delivering innovative pharmaceutical based health care solutions which enable people to live longer, healthier, and more active lives. RPI, located in Boulder, Colorado, was founded to capitalize on the broad potential of ribozymes for use as human therapeutics and other areas, including the identification of gene function and therapeutic target validation. RPI is also developing an anti-angiogenesis compound ANGIOZYME(TM) in collaboration with Chiron Corporation. ANGIOZYME is in Phase I clinical trials. This release may contain forward-looking statements that reflect management's current views of future events and operations. The information is based on management's current expectations but actual results may differ materially due to various factors, including those mentioned in this release, risks and uncertainties, including market conditions, competitive pricing, the successful outcome of clinical trials, the timely receipt of regulatory approvals and those outlined in Lilly and RPI filings with the SEC. [ * ] Confidential treatment requested XXXXXXXX X MANUFACTURING RESPONSIBILITIES DOCUMENT (MRD) TABLE OF CONTENTS GUIDELINE (Bulk Drug Substance) [ * ] [ * ] Confidential treatment requested Xxxxxxxx X XXXXXXXXXXX / XXXXXXXX [ * ] Confidential treatment requested
Sample 1
We believe xxxxx xx xxxxxxxxxxx xpportunity for this unique dose combination to contribute to pain management and this agreement allows us to bring this product to market at least 12 months earlier than expected. This acquisition will be accretive following the launch of the product, and this unique Darvocet(TM) line extension will be one of the key drivers of near-term growth for aaiPharma's pain management offering." The total propoxyphene market, generic and branded, is valued at more than $500 million, according to 2002 Verispan data. This new, unique Darvocet(TM) line extension is expected to add substantial value to aaiPharma's growing portfolio of branded pain management products. Separate from this acquisition, aaiPharma plans to launch another Darvon(R) line extension later this year, in addition to the launch of Darvon(R) Compound 32, which was announced in June 2003. ABOUT AAIPHARMA --------------- aaiPharma Inc. is a leading, science-based specialty pharmaceutical company with corporate headquarters in Wilmington, North Carolina. With more than 23 years of drug development expertise and a proven sales and marketing track record, the Company is focused on acquiring, improving and marketing well-known, branded medicines in pain management, gastroenterology and critical care. In addition to its branded product portfolio and robust pipeline, aaiPharma continues to offer comprehensive drug development services to the pharmaceutical, biotechnology, generic and device industries through its services division, AAI Development Services. For more information, please visit aaiPharma's website at www.aaipharma.com.
Sample 1
We believe we operate one of the largest repair and refurbishment networks in North America..." Exhibit D Form of Lock-Up Agreement May 17, 2006 Bear, Xxxxxxx & Co. Inc. Banc of America Securities LLC c/o Bear, Xxxxxxx & Co. Inc. 000 Xxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Equity Capital Markets The Greenbrier Companies, Inc. Lock-Up Agreement Ladies and Gentlemen: This letter agreement (this "Agreement") relates to the proposed offering (the "Offering") by The Greenbrier Companies, Inc., an Oregon corporation (the "Company"), of its 2.375% Convertible Senior Notes due 2026 (the "Notes") in an aggregate principal amount of up to $100 million (including the Initial Purchasers' over-allotment option). In order to induce you (the "Initial Purchasers") to purchase Notes in the Offering, the undersigned hereby agrees that, without the prior written consent of Bear, Xxxxxxx & Co. Inc. ("Bear Xxxxxxx"), during the period from the date hereof until sixty (60) days from the date of the final offering memorandum for the Offering (the "Lock-Up Period"), the undersigned (a) will not, directly or indirectly, offer, sell, agree to offer or sell, solicit offers to purchase, grant any call option or purchase any put option with respect to, pledge, borrow or otherwise dispose of any Relevant Security (as defined below), and (b) will not establish or increase any "put equivalent position" or liquidate or decrease any "call equivalent position" with respect to any Relevant Security (in each case within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder), or otherwise enter into any swap, derivative or other transaction or arrangement that transfers to another, in whole or in part, any economic consequence of ownership of a Relevant Security, whether or not such transaction is to be settled by delivery of Relevant Securities, other securities, cash or other consideration; provided, however, that the foregoing restrictions shall not preclude or otherwise limit (i) the transfer to the Company of common stock of the Company, no par value ("Common Stock"), in connection with the exercise of outstanding options to purchase that are scheduled to expire during the 60-day period solely to pay the option exercise price or any taxes required to be withheld by the Company to the extent such transfer is permitted to satisfy such obligations pursuant to the Company's equity compensation plans or the agreements...
Sample 1

Examples of We believe in a sentence

  • We believe that our audits provide a reasonable basis for our opinion.

  • We believe that our examination provides a reasonable basis for our opinion.

  • We believe that our audit provides a reasonable basis for our opinion.

  • We believe that the evidence we obtained is sufficient and appropriate to provide a reasonable basis for our opinion.

  • We believe that our audits provide a reasonable basis for the opinion expressed above.

  • We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

  • We believe that the exchange will be treated as a non-taxable exchange.

  • We believe that our examination provides, and that the evidence we obtained is sufficient and appropriate to provide, a reasonable basis for our opinion.

  • We believe these options are unlikely to be exercised in the foreseeable future.

  • We believe that the evidence we obtained is sufficient and appropriate to provide a reasonable basis for our opinion.Our examination does not provide a legal determination on the Company’s compliance with the servicing criteria.As described in management’s assertion, for servicing criteria 1122 (d)(4)(xi), the Company has engaged a vendor to perform the activities required by this servicing criteria.

Related to We believe

  • believe anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Readers are cautioned that forward‐looking information contained in this new release is not based on historical facts but instead is based on reasonable assumptions and estimates of management. Forward‐looking information contained in this news release includes, but is not limited to: the ability to enter into definitive documentation in respect of letters of intent currently entered into by Tidal Royalty, the ability of Tidal Royalty to enter into additional letters of intent and associated definitive documentation with current or further proposed investee companies, the closing of a transaction in respect of which definitive documents have been executed, the operating and financial performance, including planned expansions, of any investee company to be funded by Tidal Royalty from time to time and the ability of Tidal Royalty to generate revenue or realize profit through royalty agreements or equity investments with any future investee companies. In addition, this news release contains forward‐looking statements attributed to third‐party sources, the accuracy of which has not been independently verified by Xxxxx Xxxxxxx. Forward‐looking information contained herein is based on the opinions and reasonable assumptions and estimates of management as at the date hereof and is subject to a variety of known and unknown risks and uncertainties and other factors, many of which are beyond the control of Tidal Royalty, that could cause actual events or results of Tidal Royalty to differ materially from those expressed or implied in the forward‐looking information. Such factors include: U.S. regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change, risks relating to anti‐money laundering laws and regulation, other governmental and environmental regulation, public opinion and perception of the cannabis industry, risks related to the enforceability of contracts, the requirement by Tidal Royalty to obtain additional financing, the limited operating history of Tidal Royalty, timeliness of government approvals for granting of permits and licences needed by any future investee companies, including licences to cultivate cannabis, the actual operating and financial performance of any future investee company, competition and other risks affecting Tidal Royalty in particular and the U.S. cannabis industry generally, and the risk factors effecting Tidal Royalty disclosed in the listing statement of Tidal Royalty available at xxx.xxxxx.xxx. Because of such risks, uncertainties and other factors, investors should not place undue reliance on the forward‐looking information contained herein. Tidal Royalty is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward‐looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. The foregoing statements expressly qualify the forward‐looking information contained herein. This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States.

  • Lead means the referral by a franchisor to a franchisee of a potential customer

  • believes “expects”, “aims”, “intends”, “will”, “may”, “shall”, “should”, “anticipates”, “estimates”, “projects”, “is subject to”, “budget”, “scheduled”, “forecast” or words or terms of similar substance or the negative thereof, are forward looking statements. Forward looking statements include statements relating to the following: (i) future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; (ii) business and management strategies and the expansion and growth of Bidco’s or Xxxx Xxxxx’x operations and potential synergies resulting from the Acquisition; and (iii) the effects of government regulation on Bidco’s or Xxxx Xxxxx’x business. Such forward looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Bidco and Xxxx Xxxxx about future events, and are therefore subject to risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results to differ materially from those projected or implied in any forward looking statements, including: increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the timing and success of future acquisition opportunities or major investment projects. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward looking statements. Such forward looking statements should therefore be construed in the light of such factors. Neither Bidco nor Xxxx Xxxxx, nor any of their respective associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward looking statements in this Announcement will actually occur. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward looking statements, which speak only as of the date hereof. All subsequent oral or written forward looking statements attributable to any member of the Bidco Group or the Xxxx Xxxxx Group, or any of their respective associates, directors, officers, employees or advisers, are expressly qualified in their entirety by the cautionary statement above. Bidco and Xxxx Xxxxx expressly disclaim any obligation to update any forward looking or other statements contained herein, except as required by applicable law or by the rules of any competent regulatory authority, whether as a result of new information, future events or otherwise.

  • Advise means the act of sending an Advice from Broker.

  • Life-threatening means that the subject was at immediate risk of death from the AE as it occurred or it is suspected that use or continued use of the product would result in the subject’s death. ‘Life-threatening’ does not mean that had an AE occurred in a more severe form it might have caused death (eg, hepatitis that resolved without hepatic failure).

  • the Company’s knowledge as used herein shall mean the actual knowledge of Xxxx Xxxxxxx, Xxxx XxXxxxxx and Xxxxx Xxxxxxxxx.

  • Identity fraud means the act of knowingly transferring or using, without lawful authority, a means of identification of an insured. This must be done with the intent to commit, or to aid or abet another to commit, an unlawful activity that constitutes a violation of federal law or a crime under any applicable state or local law.

  • Notify “notice” or “request” means apply approve approval consent direct notify notice or request (as the case may be) in writing;

  • Reasonable grounds means that a reasonable person in your position would also suspect the information indicates misconduct or a breach of the law.

  • Larceny or Embezzlement means larceny or embezzlement as defined in Section 37 of the Investment Company Act of 1940.